Molecular pathology research has shown that dysregulated activation of the PI3Kα pathway plays a key role in HNSCC progression, primarily driven by gain-of-function mutations in PIK3CA. The gene discussed is PIK3CA; the disease is head and neck squamous cell carcinoma.